Derleme
BibTex RIS Kaynak Göster

Obezite ve Böbrek Hastalıkları

Yıl 2017, Cilt: 12 Sayı: 2, 91 - 96, 31.07.2017

Öz

Obezite, tüm dünyada ve ülkemizde sıklığı epidemi şeklinde artan, tedavisi güç,

sistemler üzerine etkileri olan, kronik, metabolik bir hastalıktır. Obezite artmış

yağ dokunun neden olduğu birden fazla mekanizma ve beraberinde gelişen

Diabetes Mellitus (DM), Hipertansiyon (HT) ve metabolik sendromun yol açtığı

etkilerle böbrek hasarına neden olmaktadır. Bu hastalıkların gelişimine engel olan

stratejiler ile böbrek hastalıklarının oluşma riski azaltılabilir. Bu stratejiler;

sağlıklı beslenme, fiziksel egzersiz, sağlıklı sıvı alımı ve yeterli uykunun

sağlanmasıdır. Obezite riskine yönelik planlanan eğitimler ve farkındalığın

artması, uygun beslenme ve egzersizi içeren sağlıklı yaşam davranışları obezitenin

neden olduğu böbrek hastalıklarının önlenmesinde oldukça etkilidir. Obezite ile

mücadelede sadece bireysel önlemler değil yönetimsel önlemlerin de alınması

oldukça önem taşımaktadır.

Kaynakça

  • 1. Akbulut GÇ, Özmen MM, Besler T. Çağın Hastalığı Obezite. Bilim ve Teknik Dergisi. Tübitak. 2007; Mart: 2-15. www.biltek.tubitak.gov.tr/bdergi/yeniufuk/icerik/obezite.pdf. (Alınma Tarihi: 20.02.2017).
  • 2. Altunkaynak BZ, Özbek E. Obezite: Nedenleri ve Tedavi Seçenekleri. Van Tıp Dergisi 2006;13(4):138-142.
  • 3. Styne DM. Childhood and Adolescent Obesity: Prevalence and Significance. Pediatric Clinics of North America 2001;48(4):823-854.
  • 4. TEMD Obezite, Lipid Metabolizması, Hipertansiyon Çalışma Grubu. Obezite Tanı ve Tedavi Kılavuzu, Türkiye Endokrinoloji ve Metabolizma Derneği 2017: 11-19.
  • 5. Eker E, Şahin M. Birinci Basamakta Obeziteye Yaklaşım. Sted 2002;11(7):246-249.
  • 6. Güler Y, Gönener HD, Altay B, Gönener A. Adölesanlarda Obezite ve Hemşirelik Bakımı. Fırat Sağlık Hizmetleri Dergisi 2009;4(10):165.
  • 7. TC. Sağlık Bakanlığı Türkiye Halk Sağlığı Kurumu. Obezite Nasıl Saptanır?. http://thsk.saglik.gov.tr/obezitesismanlik/ 769-obezite-nas%C4%B1l-saptan%C4%B1r.html. (Alınma Tarihi: 20.02.2017).
  • 8. Tsigos C, Hainer V, Basdevant A, Finer N, Fried M, Mathus-Vliegen E, et al. Management of Obesity in Adults: European Clinical Practice Guidelines. Obesity Facts 2008;1:106-116.
  • 9. Türkiye Sağlıklı Beslenme ve Hareketli Hayat Programı (2013-2017). Sağlık Bakanlığı Türkiye Halk Sağlığı Kurumu 2013; Ankara.
  • 10. World Health Organization. Obesity and overweight. http://www.who.int/mediacentre/factsheets/ fs311/en/index.html. (Alınma Tarihi: 20.02.2017).
  • 11. Global Health Observatory data repository. Obesity (body massindex ≥ 30), age-standardized (%) Global estimates. http://apps.who.int/gho/data/view.main.GLOBAL2480A?lang=en. (Alınma Tarihi: 20.02.2017).
  • 12. Global Health Observatory (GHO) data: Obesity. http://www.who.int/gho/ncd/risk_factors/obesity_text/en/. (Alınma Tarihi: 20.02.2017).
  • 13. Türkiye İstatistik Kurumu. 2015. http://www.tuik.gov.tr/basinOdasi/haberler/2015_58_20151008.pdf. (Alınma Tarihi: 20.02.2017).
  • 14. McKinney L, Skolnik N, Chrusch A. Diagnosisand Management of Obesity. Topline Information for Today’s Family Physician. American Academy of Family Physicians. 2013. www.aafp.org.
  • 15. Adult Obesity. CDC Vital Signs. 2010. www http://www.cdc.gov/mmwr. 83. (Alınma Tarihi: 10.02.2017).
  • 16. Kidney Disease&Obesity. http://www.worldkidneyday.org/wp-content/uploads/2017/02/WKD-WOF_Joint-Position.pdf. (Alınma Tarihi: 02.06.2017).
  • 17. Hariharan D, Vellanki K, Kramer H. The Western Diet and Chronic Kidney Disease. Curr Hypertens Rep 2015;17:16.
  • 18. Junior GBS, Bentes ASN, Daher EF, Matos SMA. Obesity and Kidney Disease. J BrasNefrol. 2017;39 (1): 65-69.
  • 19. Kovesdy CP, Furth SL, Zoccali C, World Kidney Day Steering Committee. Obesity and kidney disease: hidden consequences of the epidemic. J Nephrol. 2017 Feb;30(1):1-10.
  • 20. Johansen KL, Lee C. Body composition in chronic kidney disease. Curr Opin Nephrol Hypertens 2015;24:268-275.
  • 21. Hall JE, Henegar JR, Dwyer TM, Liu J, Silva AA, Kuo JJ, et al. Is obesity a majör cause of chronic kidney disease? Adv Ren ReplaceTher 2004;11:41-54.
  • 22. Bi H, Wu Y, Zhao C, Long G. Association between the dietary factors and metabolic syndrome with chronic kidney disease in Chinese adults. Int J ClinExpMed 2014;7:4448-4454.
  • 23. Wang J, Li X, Han X, Yang K, Liu B, Li Y, et al. Serum creatinin elevels and risk of metabolic syndrome in a middleaged and older Chinese population. Clin Chim Acta 2015;440:177-182.
  • 24. Blüher M. The distinction of metabolically 'healthy' from 'unhealthy' obese individuals. Curr Opin Lipidol 2010;21:38- 43.
  • 25. He Y, Liu D, Tan W, Ma X, Lian F et al. Association Between Body Mass Index and Mildly Decreased Estimated Glomerular Filtration Rate in Chinese Adults With Early Chronic Kidney Disease. J Ren Nutr. 2016 Nov;26(6):367-372.
  • 26. Smyth A, Griffin M, Yusuf S, Mann JF, Reddan D et al. Diet and Major Renal Outcomes: A Prospective Cohort Study. The NIH-AARP Diet and Health Study. J Ren Nutr. 2016 Sep;26(5):288-298.
  • 27. Physical Activity. http://www.cdc.gov/physicalactivity. (Alınma Tarihi: 02.06.2017). Obezite ve Böbrek Hastalıkları 6 Türk Nefroloji, Diyaliz ve Transplantasyon Hemşireleri Derneği Nefroloji Hemşireliği Dergisi 2017:2 (12)
  • 28. Nagasawa Y, Yamamoto R, Shinzawa M, Hasuike Y, Kuragano T et al. Body Mass Index Modifies an Association between Self-Reported Regular Exercise and Proteinuria. J Atheroscler Thromb. 2016;23(4):402-412.
  • 29. Bolignano D, Zoccali C. Effects of weightloss on renal function in obese CKD patients: a systematic review. Nephrol Dial Transplant 2013;28:iv82-98.
  • 30. Leehey DJ, Collins E, Kramer HJ, Cooper C, Butler J et al. Structured Exercise in Obese Diabetic Patients with Chronic Kidney Disease: A Randomized Controlled Trial. Am J Nephrol. 2016;44(1):54-62.
  • 31. Navaneethan SD, Fealy CE, Scelsi AC, Arrigain S, Malin SK et al. A Trial of Lifestyle Modification on Cardiopulmonary, Inflammatory, and Metabolic Effects among Obese with Chronic Kidney Disease. Am J Nephrol. 2015;42(4):274-281.
  • 32. Feehally J, Khosravi M. Effects of acute and chronic hypohydration on kidney health and function. NutrRev. 2015 Sep;73 Suppl2:110-119.
  • 33. Ferraro PM, Taylor EN, Gambaro G, Curhan GC. Dietary and Lifestyle Risk Factors Associated with Incident Kidney Stones in Men and Women. J Urol. 2017 Mar 29. pii: S0022-5347(17)43809-2.
  • 34. Obligado SH, Goldfarb DS. The association of nephrolithiasis with hypertension and obesity: a review. Am J Hypertens. 2008; 21:257-264.
  • 35. Taylor EN, Stampfer MJ, Curhan GC. Obesity, weight gain, and the risk of kidney stones. J Am Med Assoc. 2005; 293:455-462.
  • 36. Frassetto L, Kohlstadt I. Treatment and prevention of kidney stones: an update. Am Fam Physician. 2011 Dec 1;84(11): 1234-1242.
  • 37. Santos-Camilo M, Arães SP, Hirotsu C, Tufik S, Andersen ML. Correlation between obesity and chronic kidneydisease: is obstructive sleep apnea an interfering factor?.Ther Clin Risk Manag. 2016 Jul 11;12:1093-1094.
  • 38. Yayan J, Rasche K, Vlachou A. Obstructive Sleep Apnea and Chronic Kidney Disease. Adv Exp Med Biol. 2017 Jun 1-8
Yıl 2017, Cilt: 12 Sayı: 2, 91 - 96, 31.07.2017

Öz

Kaynakça

  • 1. Akbulut GÇ, Özmen MM, Besler T. Çağın Hastalığı Obezite. Bilim ve Teknik Dergisi. Tübitak. 2007; Mart: 2-15. www.biltek.tubitak.gov.tr/bdergi/yeniufuk/icerik/obezite.pdf. (Alınma Tarihi: 20.02.2017).
  • 2. Altunkaynak BZ, Özbek E. Obezite: Nedenleri ve Tedavi Seçenekleri. Van Tıp Dergisi 2006;13(4):138-142.
  • 3. Styne DM. Childhood and Adolescent Obesity: Prevalence and Significance. Pediatric Clinics of North America 2001;48(4):823-854.
  • 4. TEMD Obezite, Lipid Metabolizması, Hipertansiyon Çalışma Grubu. Obezite Tanı ve Tedavi Kılavuzu, Türkiye Endokrinoloji ve Metabolizma Derneği 2017: 11-19.
  • 5. Eker E, Şahin M. Birinci Basamakta Obeziteye Yaklaşım. Sted 2002;11(7):246-249.
  • 6. Güler Y, Gönener HD, Altay B, Gönener A. Adölesanlarda Obezite ve Hemşirelik Bakımı. Fırat Sağlık Hizmetleri Dergisi 2009;4(10):165.
  • 7. TC. Sağlık Bakanlığı Türkiye Halk Sağlığı Kurumu. Obezite Nasıl Saptanır?. http://thsk.saglik.gov.tr/obezitesismanlik/ 769-obezite-nas%C4%B1l-saptan%C4%B1r.html. (Alınma Tarihi: 20.02.2017).
  • 8. Tsigos C, Hainer V, Basdevant A, Finer N, Fried M, Mathus-Vliegen E, et al. Management of Obesity in Adults: European Clinical Practice Guidelines. Obesity Facts 2008;1:106-116.
  • 9. Türkiye Sağlıklı Beslenme ve Hareketli Hayat Programı (2013-2017). Sağlık Bakanlığı Türkiye Halk Sağlığı Kurumu 2013; Ankara.
  • 10. World Health Organization. Obesity and overweight. http://www.who.int/mediacentre/factsheets/ fs311/en/index.html. (Alınma Tarihi: 20.02.2017).
  • 11. Global Health Observatory data repository. Obesity (body massindex ≥ 30), age-standardized (%) Global estimates. http://apps.who.int/gho/data/view.main.GLOBAL2480A?lang=en. (Alınma Tarihi: 20.02.2017).
  • 12. Global Health Observatory (GHO) data: Obesity. http://www.who.int/gho/ncd/risk_factors/obesity_text/en/. (Alınma Tarihi: 20.02.2017).
  • 13. Türkiye İstatistik Kurumu. 2015. http://www.tuik.gov.tr/basinOdasi/haberler/2015_58_20151008.pdf. (Alınma Tarihi: 20.02.2017).
  • 14. McKinney L, Skolnik N, Chrusch A. Diagnosisand Management of Obesity. Topline Information for Today’s Family Physician. American Academy of Family Physicians. 2013. www.aafp.org.
  • 15. Adult Obesity. CDC Vital Signs. 2010. www http://www.cdc.gov/mmwr. 83. (Alınma Tarihi: 10.02.2017).
  • 16. Kidney Disease&Obesity. http://www.worldkidneyday.org/wp-content/uploads/2017/02/WKD-WOF_Joint-Position.pdf. (Alınma Tarihi: 02.06.2017).
  • 17. Hariharan D, Vellanki K, Kramer H. The Western Diet and Chronic Kidney Disease. Curr Hypertens Rep 2015;17:16.
  • 18. Junior GBS, Bentes ASN, Daher EF, Matos SMA. Obesity and Kidney Disease. J BrasNefrol. 2017;39 (1): 65-69.
  • 19. Kovesdy CP, Furth SL, Zoccali C, World Kidney Day Steering Committee. Obesity and kidney disease: hidden consequences of the epidemic. J Nephrol. 2017 Feb;30(1):1-10.
  • 20. Johansen KL, Lee C. Body composition in chronic kidney disease. Curr Opin Nephrol Hypertens 2015;24:268-275.
  • 21. Hall JE, Henegar JR, Dwyer TM, Liu J, Silva AA, Kuo JJ, et al. Is obesity a majör cause of chronic kidney disease? Adv Ren ReplaceTher 2004;11:41-54.
  • 22. Bi H, Wu Y, Zhao C, Long G. Association between the dietary factors and metabolic syndrome with chronic kidney disease in Chinese adults. Int J ClinExpMed 2014;7:4448-4454.
  • 23. Wang J, Li X, Han X, Yang K, Liu B, Li Y, et al. Serum creatinin elevels and risk of metabolic syndrome in a middleaged and older Chinese population. Clin Chim Acta 2015;440:177-182.
  • 24. Blüher M. The distinction of metabolically 'healthy' from 'unhealthy' obese individuals. Curr Opin Lipidol 2010;21:38- 43.
  • 25. He Y, Liu D, Tan W, Ma X, Lian F et al. Association Between Body Mass Index and Mildly Decreased Estimated Glomerular Filtration Rate in Chinese Adults With Early Chronic Kidney Disease. J Ren Nutr. 2016 Nov;26(6):367-372.
  • 26. Smyth A, Griffin M, Yusuf S, Mann JF, Reddan D et al. Diet and Major Renal Outcomes: A Prospective Cohort Study. The NIH-AARP Diet and Health Study. J Ren Nutr. 2016 Sep;26(5):288-298.
  • 27. Physical Activity. http://www.cdc.gov/physicalactivity. (Alınma Tarihi: 02.06.2017). Obezite ve Böbrek Hastalıkları 6 Türk Nefroloji, Diyaliz ve Transplantasyon Hemşireleri Derneği Nefroloji Hemşireliği Dergisi 2017:2 (12)
  • 28. Nagasawa Y, Yamamoto R, Shinzawa M, Hasuike Y, Kuragano T et al. Body Mass Index Modifies an Association between Self-Reported Regular Exercise and Proteinuria. J Atheroscler Thromb. 2016;23(4):402-412.
  • 29. Bolignano D, Zoccali C. Effects of weightloss on renal function in obese CKD patients: a systematic review. Nephrol Dial Transplant 2013;28:iv82-98.
  • 30. Leehey DJ, Collins E, Kramer HJ, Cooper C, Butler J et al. Structured Exercise in Obese Diabetic Patients with Chronic Kidney Disease: A Randomized Controlled Trial. Am J Nephrol. 2016;44(1):54-62.
  • 31. Navaneethan SD, Fealy CE, Scelsi AC, Arrigain S, Malin SK et al. A Trial of Lifestyle Modification on Cardiopulmonary, Inflammatory, and Metabolic Effects among Obese with Chronic Kidney Disease. Am J Nephrol. 2015;42(4):274-281.
  • 32. Feehally J, Khosravi M. Effects of acute and chronic hypohydration on kidney health and function. NutrRev. 2015 Sep;73 Suppl2:110-119.
  • 33. Ferraro PM, Taylor EN, Gambaro G, Curhan GC. Dietary and Lifestyle Risk Factors Associated with Incident Kidney Stones in Men and Women. J Urol. 2017 Mar 29. pii: S0022-5347(17)43809-2.
  • 34. Obligado SH, Goldfarb DS. The association of nephrolithiasis with hypertension and obesity: a review. Am J Hypertens. 2008; 21:257-264.
  • 35. Taylor EN, Stampfer MJ, Curhan GC. Obesity, weight gain, and the risk of kidney stones. J Am Med Assoc. 2005; 293:455-462.
  • 36. Frassetto L, Kohlstadt I. Treatment and prevention of kidney stones: an update. Am Fam Physician. 2011 Dec 1;84(11): 1234-1242.
  • 37. Santos-Camilo M, Arães SP, Hirotsu C, Tufik S, Andersen ML. Correlation between obesity and chronic kidneydisease: is obstructive sleep apnea an interfering factor?.Ther Clin Risk Manag. 2016 Jul 11;12:1093-1094.
  • 38. Yayan J, Rasche K, Vlachou A. Obstructive Sleep Apnea and Chronic Kidney Disease. Adv Exp Med Biol. 2017 Jun 1-8
Toplam 38 adet kaynakça vardır.

Ayrıntılar

Konular Hemşirelik
Bölüm Makale
Yazarlar

Hülya Kankaya

Ayfre Karadakovan

Yayımlanma Tarihi 31 Temmuz 2017
Yayımlandığı Sayı Yıl 2017 Cilt: 12 Sayı: 2

Kaynak Göster

Vancouver Kankaya H, Karadakovan A. Obezite ve Böbrek Hastalıkları. NefroHemDergi. 2017;12(2):91-6.

Nefroloji Hemşireliği Dergisi/ Journal of Nephrology Nursing Creative Commons Lisansı Creative Commons Atıf-GayriTicari-Türetilemez 4.0 Uluslararası Lisansı ile lisanslanmıştır.